Literature DB >> 27909809

Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy.

David N Louis1, Ken Aldape2, Daniel J Brat3, David Capper4,5, David W Ellison6, Cynthia Hawkins7, Werner Paulus8, Arie Perry9, Guido Reifenberger10,11, Dominique Figarella-Branger12, Pieter Wesseling13,14, Tracy T Batchelor15, J Gregory Cairncross16, Stefan M Pfister17,18,19, Stefan Rutkowski20, Michael Weller21, Wolfgang Wick18,22,23, Andreas von Deimling4,5.   

Abstract

Mesh：

Year:  2017        PMID： 27909809     DOI： 10.1007/s00401-016-1646-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  35 in total

1.  The ABCs of molecular diagnostic testing of CNS tumors: acceptance, benefits, costs.

Authors:  Pieter Wesseling
Journal:  Neuro Oncol       Date:  2019-05-06       Impact factor: 12.300

Review 2.  The cIMPACT-NOW updates and their significance to current neuro-oncology practice.

Authors:  L Nicolas Gonzalez Castro; Pieter Wesseling
Journal:  Neurooncol Pract       Date:  2020-08-29

Review 3.  Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults.

Authors:  Floris P Barthel; Kevin C Johnson; Pieter Wesseling; Roel G W Verhaak
Journal:  Neurol Clin       Date:  2018-08       Impact factor: 3.806

Review 4.  Neuro-Oncology and Radiogenomics: Time to Integrate?

Authors:  A Lasocki; M A Rosenthal; S J Roberts-Thomson; A Neal; K J Drummond
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-10       Impact factor: 3.825

5.  Analogous survival for patients with glioblastoma diagnosed by either histopathological or molecular features.

Authors:  Patrick J Cimino
Journal:  Neuro Oncol       Date:  2020-04-15       Impact factor: 12.300

6.  cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".

Authors:  Daniel J Brat; Kenneth Aldape; Howard Colman; Eric C Holland; David N Louis; Robert B Jenkins; B K Kleinschmidt-DeMasters; Arie Perry; Guido Reifenberger; Roger Stupp; Andreas von Deimling; Michael Weller
Journal:  Acta Neuropathol       Date:  2018-09-26       Impact factor: 17.088

Review 7.  Pediatric low-grade gliomas: next biologically driven steps.

Authors:  David T W Jones; Mark W Kieran; Eric Bouffet; Sanda Alexandrescu; Pratiti Bandopadhayay; Miriam Bornhorst; David Ellison; Jason Fangusaro; Michael J Fisher; Nicholas Foreman; Maryam Fouladi; Darren Hargrave; Cynthia Hawkins; Nada Jabado; Maura Massimino; Sabine Mueller; Giorgio Perilongo; Antoinette Y N Schouten van Meeteren; Uri Tabori; Katherine Warren; Angela J Waanders; David Walker; William Weiss; Olaf Witt; Karen Wright; Yuan Zhu; Daniel C Bowers; Stefan M Pfister; Roger J Packer
Journal:  Neuro Oncol       Date:  2018-01-22       Impact factor: 12.300

8.  Brachyury Is Associated with Glioma Differentiation and Response to Temozolomide.

Authors:  Filipe Pinto; Ângela M Costa; Raquel P Andrade; Rui Manuel Reis
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 9.  Extent of Resection of Glioblastoma: A Critical Evaluation in the Molecular Era.

Authors:  Daniel P Cahill
Journal:  Neurosurg Clin N Am       Date:  2020-11-05       Impact factor: 2.509

Review 10.  The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment.

Authors:  Henry Rodriguez; Jean Claude Zenklusen; Louis M Staudt; James H Doroshow; Douglas R Lowy
Journal:  Cell       Date:  2021-04-01       Impact factor: 41.582
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.